Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis

Journal of Hepatology

Volumn 58, Issue 3, 2013, Pages 529-534

  Weiler Normann, Christina ^a   Schramm, Christoph ^a   Quaas, Alexander ^a   Wiegard, Christiane ^a   Glaubke, Claudia ^a   Pannicke, Nadine ^a   Möller, Sina ^a   Lohse, Ansgar W ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Autoimmune hepatitis; Infliximab; Rescue treatment

Indexed keywords

ADALIMUMAB; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN G ANTIBODY; INFLIXIMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; COHORT ANALYSIS; DEPRESSION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EYE INFECTION; FEMALE; HERPES SIMPLEX; HERPES ZOSTER; HOSPITALIZATION; HUMAN; INFECTIOUS COMPLICATION; LOW DRUG DOSE; MALE; MEDICAL RECORD REVIEW; OFF LABEL DRUG USE; OSTEOPOROSIS; PANCREATITIS; PATIENT MONITORING; PNEUMONIA; PRIORITY JOURNAL; RECURRENT INFECTION; REMISSION; RETROSPECTIVE STUDY; SALVAGE THERAPY; SIDE EFFECT; TOXIC HEPATITIS; TREATMENT DURATION; TREATMENT RESPONSE; URINARY TRACT INFECTION; WEIGHT GAIN;

ADULT; AGED; ALANINE TRANSAMINASE; ANTIBODIES, MONOCLONAL; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84874110062     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.11.010     Document Type: Article

References (32)

1. A.W. Lohse, and G. Mieli-Vergani Autoimmune hepatitis J Hepatol 55 2011 171 182
2. C. Schramm, C. Weiler-Normann, C. Wiegard, S. Hellweg, S. Muller, and A.W. Lohse Treatment response in patients with autoimmune hepatitis Hepatology 52 2010 2247 2248
3. M.P. Manns, A.J. Czaja, J.D. Gorham, E.L. Krawitt, G. Mieli-Vergani, and D. Vergani Diagnosis and management of autoimmune hepatitis Hepatology 51 2010 2193 2213
4. M.P. Manns, M. Woynarowski, W. Kreisel, Y. Lurie, C. Rust, and E. Zuckerman Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis Gastroenterology 139 2010 1198 1206
5. E.M. Hennes, Y.H. Oo, C. Schramm, U. Denzer, P. Buggisch, and C. Wiegard Mycophenolate mofetil as second line therapy in autoimmune hepatitis? Am J Gastroenterol 103 2008 3063 3070
6. N.K. de Boer, C.M. van Nieuwkerk, M.N. Aparicio Pages, S.Y. de Boer, L.J. Derijks, and C.J. Mulder Promising treatment of autoimmune hepatitis with 6-thioguanine after adverse events on azathioprine Eur J Gastroenterol Hepatol 17 2005 457 461
7. S. Kanzler, G. Gerken, H.P. Dienes, K.H. Meyer zum Buschenfelde, and A.W. Lohse Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis-report of three cases Z Gastroenterol 35 1997 571 578
8. R. Malekzadeh, S. Nasseri-Moghaddam, M.J. Kaviani, H. Taheri, N. Kamalian, and M. Sotoudeh Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis Dig Dis Sci 46 2001 1321 1327
9. F.S. Larsen, B. Vainer, M. Eefsen, P.N. Bjerring, and B. Adel Hansen Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis World J Gastroenterol 13 2007 3232 3236
10. S. Kanzler, H. Lohr, G. Gerken, P.R. Galle, and A.W. Lohse Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience Z Gastroenterol 39 2001 344 348
11. L. Muratori, P. Muratori, G. Lanzoni, S. Ferri, and M. Lenzi Application of the 2010 American Association for the study of liver diseases criteria of remission to a cohort of Italian patients with autoimmune hepatitis Hepatology 52 2010 1857-8
12. M.P. Karampetsou, S.N. Liossis, and P.P. Sfikakis TNF-alpha antagonists beyond approved indications: stories of success and prospects for the future QJM 103 2010 917 928
13. F. Beigel, F. Schnitzler, R. Paul Laubender, S. Pfennig, M. Weidinger, and B. Goke Formation of antinuclear and double-strand DNA antibodies and frequency of lupus-like syndrome in anti-TNF-alpha antibody-treated patients with inflammatory bowel disease Inflamm Bowel Dis 17 2010 91 98
14. C. Goujon, K. Dahel, F. Berard, I. Guillot, N. Gunera-Saad, and J.F. Nicolas Autoimmune hepatitis in two psoriasis patients treated with inflixmab J Am Acad Dermatol 63 2010 e43 e44
15. J. Agnholt, J. Kelsen, B. Brandsborg, N.O. Jakobsen, and J.F. Dahlerup Increased production of granulocyte-macrophage colony-stimulating factor in Crohn's disease-a possible target for infliximab treatment Eur J Gastroenterol Hepatol 16 2004 649 655
16. A. Young, E. Linehan, E. Hams, A.C. O'Hara Hall, A. McClurg, and J.A. Johnston Cutting edge: suppression of GM-CSF expression in murine and human T cells by IL-27 J Immunol 189 2012 2079 2083
17. H. Bruns, C. Meinken, P. Schauenberg, G. Harter, P. Kern, and R.L. Modlin Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans J Clin Invest 119 2009 1167 1177
18. C. Weiler-Normann, C. Wiegard, C. Schramm, and A.W. Lohse A case of difficult-to-treat autoimmune hepatitis successfully managed by TNF-alpha blockade Am J Gastroenterol 104 2009 2877 2878
19. F. Alvarez, P.A. Berg, F.B. Bianchi, L. Bianchi, A.K. Burroughs, and E.L. Cancado International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis J Hepatol 31 1999 929 938
20. E.M. Hennes, M. Zeniya, A.J. Czaja, A. Pares, G.N. Dalekos, and E.L. Krawitt Simplified criteria for the diagnosis of autoimmune hepatitis Hepatology 48 2008 169 176
21. A.J. Czaja Natural history, clinical features, and treatment of autoimmune hepatitis Semin Liver Dis 4 1984 1 12
22. M.M. Lamers, M.G. van Oijen, M. Pronk, and J.P. Drenth Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials J Hepatol 53 2010 191 198
23. K. Zachou, N. Gatselis, G. Papadamou, E.I. Rigopoulou, and G.N. Dalekos Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients J Hepatol 2011
24. K. Sharzehi, M.A. Huang, I.R. Schreibman, and K.A. Brown Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy Can J Gastroenterol 24 2010 588 592
25. C. Schramm, and A.W. Lohse Role of mycophenolate mofetil in the treatment of autoimmune hepatitis J Hepatol 55 2011 510 511
26. M. Cuarterolo, M. Ciocca, C.C. Velasco, M. Ramonet, T. Gonzalez, and S. Lopez Follow-up of children with autoimmune hepatitis treated with cyclosporine J Pediatr Gastroenterol Nutr 43 2006 635 639
27. F.S. Larsen Treatment of patients with severe autoimmune hepatitis Minerva Gastroenterol Dietol 54 2008 57 63
28. A.C. Ford, W.J. Sandborn, K.J. Khan, S.B. Hanauer, N.J. Talley, and P. Moayyedi Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis Am J Gastroenterol 106 2011 644 659 [660]
29. M.P. Karampetsou, S.N. Liossis, and P.P. Sfikakis TNF-alpha antagonists beyond approved indications: stories of success and prospects for the future QJM 103 2010 917 928
30. I. Kirman, R.L. Whelan, and O.H. Nielsen Infliximab: mechanism of action beyond TNF-alpha neutralization in inflammatory bowel disease Eur J Gastroenterol Hepatol 16 2004 639 641
31. P. Tandon, and G. Garcia-Tsao Bacterial infections, sepsis, and multiorgan failure in cirrhosis Semin Liver Dis 28 2008 26 42
32. C. Schramm, M. Bubenheim, R. Adam, V. Karam, J. Buckels, and J.G. O'Grady Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European liver transplant registry Liver Transpl 16 2010 461 469